0-4℃ for short term (days to weeks), or -20℃ for long term (months).
Afuresertib is an orally bioavailable inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | 50.00 | |
5 mg | In stock | 80.00 | |
10 mg | In stock | 110.00 | |
25 mg | In stock | 198.00 | |
50 mg | In stock | 320.00 | |
100 mg | In stock | 560.00 | |
1 mL * 10 mM (in DMSO) | In stock | 80.00 |
Description | Afuresertib is an orally bioavailable inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. |
Targets&IC50 | Akt1 :ic50 0.08nM(Ki), Akt2 :ic50 2nM(Ki), Akt3 :ic50 2.6nM(Ki), |
Kinase Assay | Potency (Ki*) of afuresertib: The true potency (Ki*) of the inhibitor is initially determined at low enzyme concentrations (0.1 nM AKT1, 0.7 nM AKT2, and 0.2 nM AKT3) using a filter binding assay and then confirmed with progress curve analysis. In the filter binding assay, a pre-mix of enzyme plus inhibitor is incubated for 1 h and then added to a GSKα peptide (Ac-KKGGRARTSS-FAEPG-amide) and [γ33P] ATP. Reactions are terminated after 2 h and the radio labeled AKT peptide product is captured in a phospho-cellulose filter plate. Progress curve analysis utilizes continuous real-time fluorescence detection of product formation using the Sox-AKT-tide substrate (Ac-ARKRERAYSF-d-Pro-Sox-Gly-NH2). |
Cell Research |
A 3-day proliferation assay using CellTiter-Glo is performed to measure the growth inhibition by the compounds at 0-30 μM. Cell growth is determined relative to untreated (DMSO) controls. EC50’s are calculated from inhibition curves using a 4- or 6-parameter fitting algorithm in the Assay Client application.(Only for Reference)
Cell lines: Hematological cell lines and solid tumor cell lines
|
Animal Research |
Animal Model: Feathymic nude and SCID mice bearing SKOV3 or BT474 tumors
|
Synonyms | GSK2110183C , GSK2110183 |
Purity | 97.51% |
Molecular Weight | 427.32 |
Formula | C18H17Cl2FN4OS |
CAS No. | 1047644-62-1 |
0-4℃ for short term (days to weeks), or -20℃ for long term (months).
DMSO: 79 mg/mL (184.9 mM)
Ethanol: 79 mg/mL (184.9 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
Safe and effective drug dosing is necessary, regardless of its purpose of administration. Learn More
bottom
Answers to questions you may have can be found in the Inhibitor Handling Instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.